Warfarin works by disrupting the vitamin K cycle, crucial for the activation of clotting factors II, VII, IX, and X. It inhibits the enzyme vitamin K epoxide reductase, reducing the synthesis of these factors and effectively slowing down the blood's ability to clot. This interference means that even if the body signals to form a clot, the necessary components are in low supply, reducing the risk of dangerous clots forming.